Creative Medical Technology Holdings, Inc. (CELZ)
1.05
-0.03
(-2.78%)
USD |
NASDAQ |
Sep 09, 15:46
Creative Medical Technology Holdings Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -7.551 |
| June 30, 2021 | -0.3111 |
| March 31, 2021 | -0.134 |
| December 31, 2020 | -0.0198 |
| September 30, 2020 | -0.3272 |
| June 30, 2020 | -0.2489 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3241 |
| December 31, 2019 | -0.1316 |
| September 30, 2019 | -0.2515 |
| June 30, 2019 | -0.4057 |
| March 31, 2019 | -0.2994 |
| December 31, 2018 | -0.1708 |
| September 30, 2018 | -0.0461 |
| June 30, 2018 | -0.0345 |
| March 31, 2018 | -0.0642 |
| December 31, 2017 | -0.2248 |
| September 30, 2017 | -0.3685 |
| June 30, 2017 | -0.2741 |
| March 31, 2017 | -0.4171 |
| December 31, 2016 | -0.8086 |
| September 30, 2016 | -0.4275 |
| June 30, 2016 | -0.5358 |
| March 31, 2016 | -0.892 |
| December 31, 2015 | -0.7067 |
| September 30, 2015 | -0.7347 |
| June 30, 2015 | -0.7473 |
| March 31, 2015 | -0.7455 |
| December 31, 2014 | -0.7582 |
| September 30, 2014 | -0.9242 |
| June 30, 2014 | -0.9276 |
| March 31, 2014 | -0.9119 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.378M |
| Total Liabilities (Quarterly) | 0.6986M |
| Shareholders Equity (Quarterly) | 8.655M |
| Current Ratio | 12.91 |